Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy Reply

被引：7
|
作者：
Zignego, Anna Linda [1 ]
Gragnani, Laura [1 ]
Visentini, Marcella [2 ]
Casato, Milvia [2 ]
机构：
[1] Univ Florence, Dept Expt & Clin Med, Interdept Ctr Syst Manifestat Hepatitis Viruses M, Florence, Italy
[2] Sapienza Univ Rome, Reg Referral Ctr Mixed Cryoglobulinemia, Policlin Umberto 1, Dept Clin Med, Rome, Italy
来源：
HEPATOLOGY | 2017年 / 65卷 / 05期
关键词：
MIXED CRYOGLOBULINEMIA;
D O I：
10.1002/hep.28977
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1771 / 1772
页数：3
相关论文
共 50 条
  • [41] Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
    Cristina Maria Muzica
    Carol Stanciu
    Laura Huiban
    Ana-Maria Singeap
    Catalin Sfarti
    Sebastian Zenovia
    Camelia Cojocariu
    Anca Trifan
    World Journal of Gastroenterology, 2020, (43) : 6770 - 6781
  • [42] Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma
    Nagaoki, Yuko
    Yamaoka, Kenji
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Aikata, Hiroshi
    Hayes, Clair Nelson
    Tsuge, Masataka
    Oka, Shiro
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
  • [43] Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: Qatar experience
    Alkadi, Mohamad M.
    Abuhelaiqa, Essa A.
    Elshirbeny, Mostafa F.
    Hamdi, Ahmed F.
    Fituri, Omar M.
    Asim, Muhammad
    Alkaabi, Saad R.
    Derbala, Moutaz F.
    Jarman, Mona E.
    Ashour, Adel M.
    Nauman, Awais
    Al Maslamani, Yousuf K.
    Butt, Adeel A.
    Al-Malki, Hassan A.
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (01) : 246 - 254
  • [44] Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy
    Toyoda, Hidenori
    Kikuchi, Kan
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (05) : 831 - 838
  • [45] Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy
    Jadoul, Michel
    Labriola, Laura
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (01) : 158 - 159
  • [46] Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient
    Chute, Donald F.
    Chung, Raymond T.
    Sise, Meghan E.
    KIDNEY INTERNATIONAL, 2018, 93 (03) : 560 - 567
  • [47] Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
    Baumert, Thomas F.
    Berg, Thomas
    Lim, Joseph K.
    Nelson, David R.
    GASTROENTEROLOGY, 2019, 156 (02) : 431 - 445
  • [48] Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
    Comarmond, Cloe
    Garrido, Marlene
    Pol, Stanislas
    Desbois, Anne-Claire
    Costopoulos, Myrto
    Le Garff-Tavernier, Magali
    Ahmed, Si Nafa Si
    Alric, Laurent
    Fontaine, Helene
    Bellier, Bertrand
    Maciejewski, Anna
    Rosenzwajg, Michelle
    Klatzmann, David
    Musset, Lucile
    Poynard, Thierry
    Cacoub, Patrice
    Saadoun, David
    GASTROENTEROLOGY, 2017, 152 (08) : 2052 - +
  • [49] Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection
    Feld, Jordan J.
    Jacobson, Ira M.
    Sulkowski, Mark S.
    Poordad, Fred
    Tatsch, Fernando
    Pawlotsky, Jean-Michel
    LIVER INTERNATIONAL, 2017, 37 (01) : 5 - 18
  • [50] The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype
    Frey, Alexandra
    Piras-Straub, Katja
    Walker, Andreas
    Timm, Joerg
    Gerken, Guido
    Herzer, Kerstin
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (01)
12345